CXCL4/PF4 is a predictive biomarker of cardiac differentiation potential of human induced pluripotent stem cells. Sci Rep. 2019;9(1):4638.
A Novel In Vitro Method for Detecting Undifferentiated Human Pluripotent Stem Cells as Impurities in Cell Therapy Products Using a Highly Efficient Culture System. PLoS One. 2014;9(10):e110496..
Tumorigenicity assessment of human cell-processed therapeutic products. Biologicals. 2015..
Tumorigenicity-associated characteristics of human iPS cell lines. PLoS One. 2018;13(10):e0205022.